Wednesday, July 21, 2021 8:23:08 PM
Yes, LCLP recently acquired AI (Artificial Intelligence) business . . .
For more, click https://finance.yahoo.com/quote/LCLP?p=LCLP&.tsrc=fin-srch and scroll down that page for these headlines I've highlighted here:
GlobeNewswire•22 days ago
Life Clips Subsidiary Cognitive Apps Software Solutions Introduces Intuitive AI Chat Bot Solutions Delivering CBT And IPT Therapies For Mental Health Disorders
Mental health is one of the biggest pandemic issues we will face in the near futureAVENTURA, Fla., June 29, 2021 (GLOBE NEWSWIRE) -- Life Clips, Inc. (OTC Pink: LCLP) (the “Company”) today announced that its subsidiary Cognitive Apps Software has introduced a game changing Chatbot solution for both cognitive behavioral therapy (CBT) and interpersonal therapy (IPT). Cognitive Apps Chatbot is an interactive assistant that makes it easy to measure, understand, and improve mental health of a person. The soon to be released version combines cognitive behavioral therapy and elements of interpersonal psychotherapy with the company’s conversational chatbot to deliver treatment directly through patients’ phones.
The solution is backed by science and based on voice tone analysis and context analysis utilizing Cognitive Apps' proprietary artificial intelligence (AI). The chatbot interaction includes revolutionary features, such as general mood analysis, actual emotion detection, and mental health state tracking. Integration with health data gathering tools (sleep, physical activity) allows receiving data in passive mode and makes mental health analytics results more accurate and objective. The chatbot will observe and improve mental health state of the individual using it. It also allows therapists to monitor patients’ mental health level, while analyzing the efficiency of prescriptions and treatment. Many enterprises will find the chatbot useful to monitor overall company mental health level, analyze return on investment, detect early signs of burnout, depression, and/or anxiety.
The chatbot works as an individual makes daily check-ins with voice or text messages. It further analyzes his or her emotions, daily mood and mental health state. For an individual the chatbot displays analysis results and suggest suitable content. For a therapist the chatbot utilizes a dashboard to display the mental health state, wellbeing statistics, and medication history for selected groups of patients, while providing an individual-level of analytics. For an enterprise the dashboard displays the data in an encrypted & non-personalized form and illumination that drives immediate decisions.
Cognitive Apps is the creator of the popular Yuru 3-in-1 tool for understanding and managing mental health. The Company recently announced a successful launch of Yuru on Apple‘s App Store. Yuru was developed by a team of licensed psychotherapists as a personal mental health monitor that screens early signs of mental health conditions, such as stress and depression. With a 10 second voice recording Yuru utilizes vocal biomarkers to recognize an individual’s current emotional state and mood. Yuru is considered by many to be an innovative application in the field of psychological assistance, since it allows individuals to track their mental health while providing them with extensive knowledge about human development and the psychology of everyday life.
GlobeNewswire•3 months ago
Life Clips, Inc. Subsidiary Cognitive Apps Signs LOI to License Yuru Technology to Belfrics BT
AVENTURA, Fla., April 28, 2021 (GLOBE NEWSWIRE) -- Life Clips, Inc. (OTC Pink: LCLP) (the “Company”) today announced that its subsidiary Cognitive Apps Software has signed a Letter of Intent (LOI) to license its Yuru software to Malaysian based BelfricsBT for use in its products in the Southeast Asian market. BelfricsBT provides a diverse mix of Blockchain related services, including Blockchain powered smart contracts and crypto exchange software, as well as custom solutions. Cognitive Apps is the creator of the popular Yuru 3-in-1 tool for understanding and managing mental health. The Company recently announced a successful launch of Yuru on Apple‘s App Store. Yuru was developed by a team of licensed psychotherapists as a personal mental health monitor that screens early signs of mental health conditions, such as stress and depression. With a 10 second voice recording Yuru utilizes vocal biomarkers to recognize an individual’s current emotional state and mood. Yuru is considered by many to be an innovative application in the field of psychological assistance, since it allows individuals to track their mental health while providing them with extensive knowledge about human development and the psychology of everyday life. Cognitive Apps is targeting employee mental health in the next phase of its rollout of Yuru. Major employers like SAP North America, a global enterprise software company are focusing on the trend toward increased employee mental health. SAP recently announced its first-ever Global Mental Health Day, giving all of its more than 100,000 employees a mandatory day off to help them recharge and balance priorities. The digital mental health space was growing rapidly before the COVID-19 pandemic, but stress and anxiety created by the pandemic have increased demand for virtual behavioral health services. According to a recent report by Acumen Research and Consulting titled “Mental Health App Market – Global Industry Analysis, Market Size, Opportunities and Forecast, 2020-2027”, the Global Mental Health App Market is expected to grow at a CAGR of around 24.2% from 2020 to 2027 and reach the market value of over US$ 3.7 billion by 2027. The report says the global mental health app market is estimated to gain potential growth over the forecast period from 2020 to 2027 due to increasing awareness about the importance of mental health among people across the globe. Mental health apps are designed to shape up the mood of the user, additionally, these apps let users connect with the licensed mental health professional and peers who can understand what they are going through. These apps also contain lots of information about mental health that helps its users to understand better about their condition. Social stigma for mental health in some regions prevents patients from visiting the concerned organization or professional additionally bolstering the number of mental health apps downloads.i Dr. Manideep Gopishetty, CEO and Co-founder of Cognitive Apps, said, “The benefits of Yuru are clear. We can provide increased access to mental healthcare at our fingertips. Not only does Yuru provide mental healthcare to those who otherwise might not have access to it, we can personalize care to meet the exact needs of the patient. Yuru provides the potential to provide care that is more affordable, personalized, and accessible.” Robert Grinberg, CEO and of Life Clips, Inc. said, "This LOI with BelfricsBT is the first of many opportunities we will have to expand the Yuru platform. In its Global Millennial Survey last year, Deloitte said that 48% of Gen Zs and 44% of millennials felt stressed or anxious all or most of the time from long-term career and financial outlooks, family welfare, and environmental concerns, among other issues. Our goal is to help with these mental health issues and improve the quality of life for those who are affected." Life Clips appreciates all of its shareholders and would like to provide them with complimentary lifetime free access to the Yuru app. Shareholders are invited to download the app on the Apple store using this link https://apps.apple.com/us/app/yuru-stress-test-self-care/id1502398978. About Life Clips, Inc. Life Clips is the parent company of Cognitive Apps Software Solutions Inc. and distributes single-use and cordless batteries under the Mobeego brand for use with cellular phones and other mobile devices. Cognitive Apps is an AI-Powered mental health analytics platform that empowers businesses to measure, understand, and improve mental well-being of their employees, patients and customers. Drug development for mental health disorders and other cognitive impairments is hampered by the inability to identify at risk groups before the onset of clinically significant symptoms, as well as continuous assessments on the progress made by the participants. Cognitive Apps is addressing this problem by pioneering a speech-based AI technology which could help accurately predict risk for various types of depression and mood and anxiety-based disorders years before a clinical diagnosis is obtained. Our technology can help detect and monitor subtle changes in mental state by assessing individuals more frequently and more objectively than the assessments used today. www.lifeclips.com About BelfricsBT BelfricsBT is the leading provider of Distributed Ledger Technology to various sectors. The Company is a group of Blockchain experts armed with rich corporate experience. Belfrics BT provides any and all kinds of Blockchain related services, including blockchain powered smart contracts and crypto exchange software. BelfricsBT's aim is to generate revolutionary Blockchain concepts and convert them into Enterprise solutions that can solve real business problems. Its coders have the experience of developing completely fresh Blockchains as well as specific blockchain applications. BelfricsBT specializes in converting complex transactions and sequence into codes. Its management team has worked with clients from various industries and geographies. As a result, BelfricsBT's team is well aware of core problems of each of these industries. www.belfricsbt.com Forward-Looking Statement Disclaimer This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may be preceded by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words. Forward-looking statements are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company's control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements: (i) the initiation, timing, progress and results of the Company’s research, manufacturing and other development efforts; (ii) the Company’s ability to advance its products to successfully complete development and commercialization; (iii) the manufacturing, development, commercialization, and market acceptance of the Company’s products; (iv) the lack of sufficient funding to finance the product development and business operations; (v) competitive companies and technologies within the Company’s industry and introduction of competing products; (vi) the Company’s ability to establish and maintain corporate collaborations; (vii) loss of key management personnel; (viii) the scope of protection the Company is able to establish and maintain for intellectual property rights covering its products and its ability to operate its business without infringing the intellectual property rights of others; (ix) potential failure to comply with applicable health information privacy and security laws and other state and federal privacy and security laws; and (x) the difficulty of predicting actions of the USA FDA and its regulations. All forward-looking statements included in this press release are made only as of the date of this press release. The Company assumes no obligation to update any written or oral forward-looking statement unless required by law. For LifeClips, Inc. Investor Relations Please Contact: David Kugelman(866) 692-6847 Toll Free - U.S. & Canada(404) 281-8556 Mobile, WhatsApp, Signal, and TelegramSkype: kugsusadk@atlcp.com https://www.linkedin.com/in/davidkugelman i https://bit.ly/3vid5rH
GlobeNewswire•3 months ago
Life Clips, Inc. Subsidiary Cognitive Apps Announces Successful Launch of Yuru Mental Health App
AVENTURA, Fla., April 19, 2021 (GLOBE NEWSWIRE) -- Life Clips, Inc. (OTC Pink: LCLP) (the “Company”) today announced that its subsidiary Cognitive Apps Software has completed a successful launch of its Yuru 3-in-1 tool for understanding and managing your mental health. The initial results on Apple‘s App Store showed a weekly download conversion rate of 5.6% on more than 189,000 impressions and 19,900 product page views. App Units were 8,500 with average sales per paying user of $28.10. App Units are the number of first-time paid and free app purchases made on the App Store using iOS 8 and tvOS 9 or later. App updates and downloads from the same Apple ID onto other devices, and redownloads to the same device are not counted. Yuru is an innovative application in the field of psychological assistance that has been developed by a team of licensed psychotherapists. Yuru is a personal mental health monitor that screens early signs of mental health conditions, such as stress and depression. In just 10 seconds, it makes use of vocal biomarkers to recognize your real current emotional state and mood, while tracking your mental health. Yuru also provides you with extensive knowledge about human development and the psychology of everyday life. Yuru involves tracking of your emotions and mood, analysis of your mental state, and treatment for improving your mental well-being. Life Clips appreciates all of its shareholders and would like to provide them with complimentary lifetime free access to the Yuru app. Shareholders are invited to download the app on the Apple store using this link https://apps.apple.com/us/app/yuru-stress-test-self-care/id1502398978. According to a December 03, 2020 article in The Harvard Business Review, the U.S. has long suffered from a severe shortage of mental health care services. The pandemic has put a spotlight on the effectiveness and wide availability of digital and virtual mental health care, and by doing so might have thrown a lifeline to our mental health system. The article went on to say sixty percent of young people with major depression received no mental health treatment in 2017-2018, and one quarter of adults with mental illness reported an unmet need for treatment. In the U.S., 55% of counties have no psychiatrist, psychologist or social worker, and 70% don’t have a single child psychiatrist. Queues for substance abuse care can be weeks long; 70% of those who needed substance use treatment in 2017 did not receive it. To make it worse, many practices have closed or reduced their capacity in response to pandemic health concerns. As a result, mental health vendors are combining digital tools and virtual care to create a robust ecosystem for end-to-end patient care, including steering patients to in-person care when needed. This combination of tools provides the mental health care system with scalable solutions and increased flexibility while improving access and convenience for consumers. Because of these benefits, the majority of employer-sponsored health plans now offer virtual and digital options for mental health care.i Dr. Manideep Gopishetty, CEO and Co-founder of Cognitive Apps, said, “The Yuru team is very pleased to see our numbers climb following this initial introduction of our mental health app. We believed our messaging was going to result in a strong source of new users due to the enormity of the market. It is the right time to aggressively market our online mental health platform. These strong early results are encouraging.” Robert Grinberg, CEO and President of Life Clips, Inc. said, "I would like to congratulate Dr. Gopishetty and his team on a successful rollout of Yuru. Yuru is a true mental health companion that warns you if it notices that you need professional guidance from a therapist. It nudges you to pay attention to your mental state if there is a change in your stress level. By analyzing vocal biomarkers received from your voice, Yuru reports a spectrum of your current emotions, your daily mood, and the overall status of your mental health. We look forward to expanding the Yuru platform, as well as making future acquisitions that are in line with our business plan." About Life Clips, Inc. Life Clips is the parent company of Cognitive Apps Software Solutions Inc. and distributes single-use and cordless batteries under the Mobeego brand for use with cellular phones and other mobile devices. Cognitive Apps is an AI-Powered mental health analytics platform that empowers businesses to measure, understand, and improve mental well-being of their employees, patients and customers. Drug development for mental health disorders and other cognitive impairments is hampered by the inability to identify at risk groups before the onset of clinically significant symptoms, as well as continuous assessments on the progress made by the participants. Cognitive Apps is addressing this problem by pioneering a speech-based AI technology which could help accurately predict risk for various types of depression and mood and anxiety-based disorders years before a clinical diagnosis is obtained. Our technology can help detect and monitor subtle changes in mental state by assessing individuals more frequently and more objectively than the assessments used today. Forward-Looking Statement Disclaimer This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may be preceded by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words. Forward-looking statements are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company's control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements: (i) the initiation, timing, progress and results of the Company’s research, manufacturing and other development efforts; (ii) the Company’s ability to advance its products to successfully complete development and commercialization; (iii) the manufacturing, development, commercialization, and market acceptance of the Company’s products; (iv) the lack of sufficient funding to finance the product development and business operations; (v) competitive companies and technologies within the Company’s industry and introduction of competing products; (vi) the Company’s ability to establish and maintain corporate collaborations; (vii) loss of key management personnel; (viii) the scope of protection the Company is able to establish and maintain for intellectual property rights covering its products and its ability to operate its business without infringing the intellectual property rights of others; (ix) potential failure to comply with applicable health information privacy and security laws and other state and federal privacy and security laws; and (x) the difficulty of predicting actions of the USA FDA and its regulations. All forward-looking statements included in this press release are made only as of the date of this press release. The Company assumes no obligation to update any written or oral forward-looking statement unless required by law. Contact: LifeClips, Inc. Gabriel P. Rodriguez Investor Relations: (623) 261-9046 Email: erelationsgroup@gmail.com i https://hbr.org/2020/12/digital-tools-are-revolutionizing-mental-health-care-in-the-u-s
GlobeNewswire•3 months ago
Life Clips, Inc. Subsidiary Cognitive Apps Recognized as One of the Most Promising AI Startups in the Healthcare and Technology Space
AVENTURA, Fla., April 15, 2021 (GLOBE NEWSWIRE) -- Life Clips, Inc. (OTC Pink: LCLP) (the “Company”) today announced that its subsidiary Cognitive Apps Software recently participated in the February 2021 Y Combinator cohort receiving an award as one of the most promising Artificial Intelligence (AI) startups in the space of healthcare and technology. This success has further validated Cognitive Apps proof of concept and has energized the entire Cognitive Apps team and motivated us to push the boundaries of innovation in the space of AI. Following this success, Cognitive Apps is developing a series of new features rolling out in coming weeks including speech to text for clinical documentation purposes in the healthcare and a series of intuitive chat bots targeting various mental health care indications. Additionally, Cognitive Apps has signed three LOI’s for the licensing of its technology to other technological companies. Cognitive Apps plans to apply its existing technology, as well as the new technologies being rolled out, disrupting industries with intuitive chatbots targeting insurance companies and corporate wellness, diagnostic monitoring tools for outpatient for hospitals and clinics, and AI diagnostic algorithms for mental healthcare clinical trials. The global chatbot market size was estimated at $352.8 million in 2019 and is expected to reach $1.250 billion by 2025.i Dr. Manideep Gopishetty, CEO and Co-founder of Cognitive Apps, said, “Receiving recognition and an award from such a highly regarded organization that has produced over 25 unicorns, is a tremendous achievement for Cognitive Apps. With this spirit and responsibility my team and I plan to push our innovation to the next level, where it can have profound impact on the mental health care and AI technology sector for the next decade.” "We are honored to have Cognitive Apps recognized as one of the most promising AI startups in healthcare and technology," said Robert Grinberg, CEO and of Life Clips, Inc. "I believe our recent acquisition of Cognitive Apps will be very beneficial to our shareholders. We look forward to building a competitive brand as we move forward with other acquisitions." About Life Clips, Inc. Life Clips is the parent company of Cognitive Apps Software Solutions Inc. and distributes single-use and cordless batteries under the Mobeego brand for use with cellular phones and other mobile devices. Cognitive Apps is an AI-Powered mental health analytics platform that empowers businesses to measure, understand, and improve mental well-being of their employees, patients and customers. Drug development for mental health disorders and other cognitive impairments is hampered by the inability to identify at risk groups before the onset of clinically significant symptoms, as well as continuous assessments on the progress made by the participants. Cognitive Apps is addressing this problem by pioneering a speech-based AI technology which could help accurately predict risk for various types of depression and mood and anxiety-based disorders years before a clinical diagnosis is obtained. Our technology can help detect and monitor subtle changes in mental state by assessing individuals more frequently and more objectively than the assessments used today. Forward-Looking Statement Disclaimer This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may be preceded by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words. Forward-looking statements are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company's control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements: (i) the initiation, timing, progress and results of the Company’s research, manufacturing and other development efforts; (ii) the Company’s ability to advance its products to successfully complete development and commercialization; (iii) the manufacturing, development, commercialization, and market acceptance of the Company’s products; (iv) the lack of sufficient funding to finance the product development and business operations; (v) competitive companies and technologies within the Company’s industry and introduction of competing products; (vi) the Company’s ability to establish and maintain corporate collaborations; (vii) loss of key management personnel; (viii) the scope of protection the Company is able to establish and maintain for intellectual property rights covering its products and its ability to operate its business without infringing the intellectual property rights of others; (ix) potential failure to comply with applicable health information privacy and security laws and other state and federal privacy and security laws; and (x) the difficulty of predicting actions of the USA FDA and its regulations. All forward-looking statements included in this press release are made only as of the date of this press release. The Company assumes no obligation to update any written or oral forward-looking statement unless required by law. Contact: Life Clips, Inc.David L. Kugelman(404) 856-9157 Office(866) 692-6847 Toll Free - U.S. & Canada(404) 281-8556 Mobile and WhatsAppSkype: kugsusadk@atlcp.com__________________ i https://www.grandviewresearch.com/industry-analysis/chatbot-market#:~:text=The%20global%20chatbot%20market%20size,USD%20430.9%20million%20in%202020.&text=The%20global%20chatbot%20market%20is,USD%201%2C250.1%20million%20by%202025.
GlobeNewswire•3 months ago
Life Clips, Inc. Issues CEO Letter to Stockholders, Reports on Outlook for Remainder of 2021
AVENTURA, Fla., April 12, 2021 (GLOBE NEWSWIRE) -- Life Clips, Inc. (OTC Pink: LCLP) (the “Company”) today announced that Robert Grinberg, President, Chief Executive Officer and Chairman, has issued a letter to Life Clips' shareholders. The full text is as follows: To My Fellow Stockholders, Over the course of the last few months, Life Clips, Inc. has made significant progress in advancing its strategic plan and we are off to a tremendous start. First, I am proud to report that Life Clips is current in its status as a fully reporting company with the SEC. This took many months of hard work by our CFO and her team of professionals. One of our primary goals moving forward will be corporate transparency. I am a firm believer that transparency pays off in the financial markets in the form of less risk to investors and a lower cost of capital for our Company, which will hopefully translate into a higher valuation. Maintaining our status as a reporting company is the foundation of providing transparency to our shareholders. Even though we are just getting started, I think it is important to discuss, not just the accomplishments of our management team, but the potential we see in Life Clips' business plan in the future. First and foremost, we were very proud to make the announcement to our shareholders this week that we closed our acquisition of Cognitive Apps Software Solutions Inc. Cognitive Apps is a developer of AI applications for the healthcare industry with applications in psychedelic research. Our enthusiasm for Cognitive Apps is based on the premise that Life Clips is now in two of the fastest growing sectors, AI and psychedelics. In addition to entering these fast-growing markets with the acquisition of Cognitive Apps, Life Clips has attained what we believe to be some of the most talented individuals in the business. Dr. Manideep Gopishetty, CEO and Co-founder of Cognitive Apps, holds several advanced degrees, including an MD and an MBA. In addition to education credentials, Dr. Gopishetty also brings a tremendous amount of experience in neuromarketing, neuroeconomics, consumer behavior, and consumer psychology in such diverse fields as healthcare, biotechnology and pharmaceuticals, SAAS, and artificial intelligence. Cognitive Apps provides an AI powered mental health analytics platform empowering businesses to measure, understand, and improve the mental well-being of their employees, patients or customers. Cognitive Apps was designed specifically to improve diagnostic outcomes, population health, and to provide a better care experience. This is accomplished by processing data into actionable insight that impacts operational benefits and patient outcomes. By recording an individual’s voice periodically on a handset, iPad, or tablet, the Cognitive Apps assessment is designed to provide a picture of changes in mental health. The Cognitive Apps’ assessment will allow us to monitor mental health and track variables that might be impacted by treatment. Cognitive Apps has participated in a Y-Combinator cohort winning credits from Google, Amazon and Microsoft, and is beginning development of AI algorithms for PTSD and Anxiety. At the root of our business plan, the force that drives us will be to improve mental health and combat mental illness. Nearly one in five U.S. adults experience some form of mental illness and one adult in 24 has a serious mental illness. Mental illness is treatable, and our mission is to treat even those with serious mental illness. Depression is a common mental disorder affecting more than 264 million people worldwide. Mental health experts have found a strong link between loneliness, depression, and drug overdoses. According to national drug abuse data, drug overdoses have increased 42% since Covid-19. Serious mental illness costs the U.S. economy $193.2 billion in lost earnings each year, but the problem is much larger globally. Mental health disorders are on the rise in every country and could cost the global economy up to $16 trillion annually by 2030. The numbers are staggering but are outweighed by the loss of human lives. We look forward to positioning Life Clips to have even a small role in the global mental health crisis. Mental health is something every one of us should be talking about. Acquiring Cognitive Apps is the first piece of the business strategy we have developed for Life Clips. Management’s business strategy targets revenue growth, profitability and value creation for our shareholders. This initial acquisition is the first of several that will allow us to broaden operations and expand into multiple markets. Since both the healthcare and psychedelic sectors are made up of many small companies, we will also plan to join forces with both publicly traded and privately held enterprises to form partnerships, joint ventures, and alliances. Life Clips also has the Mobeego line of affordable, single-use, cordless batteries that provide an instant charge for your phone when you don't have access to a wired power source and is ideally suited for emergency situations having a long shelf life, holding a charge many times longer than any mobile power bank. Mobeego connects to your mobile phone’s charging socket, and is compatible with all iPhones 5 and up, as well as most Micro USB devices. Mobeego consists of two parts: a disposable battery can that extends a mobile phone’s life by 1-4 hours, and a reusable, ultra-compact adapter. When you're ready to use Mobeego, simply connect the can to your mobile phone via the adapter, and charging will begin immediately when you switch it on. After you finish using the can, save the adapter and recycle the can. Unlike a rechargeable power bank, the Mobeego won’t lose charge when stored for extended periods, such as a part of an emergency kit. I realize it is early in the game, but we are delighted with our progress to date and are very excited about our momentum, as well as Life Clips' prospects. I would like to thank our shareholders for their vote of confidence. I learned a long time ago respect is earned, and my goal is to earn the respect of shareholders by building a successful company. We look forward to continued success in 2021 and beyond. About Life Clips, Inc. Life Clips is the parent company of Cognitive Apps Software Solutions Inc. and distributes single-use and cordless batteries under the Mobeego brand for use with cellular phones and other mobile devices. Cognitive Apps is an AI-Powered mental health analytics platform that empowers businesses to measure, understand, and improve mental well-being of their employees, patients and customers. Drug development for mental health disorders and other cognitive impairments is hampered by the inability to identify at risk groups before the onset of clinically significant symptoms, as well as continuous assessments on the progress made by the participants. Cognitive Apps is addressing this problem by pioneering a speech-based AI technology which could help accurately predict risk for various types of depression and mood and anxiety-based disorders years before a clinical diagnosis is obtained. Our technology can help detect and monitor subtle changes in mental state by assessing individuals more frequently and more objectively than the assessments used today. Forward-Looking Statement Disclaimer This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may be preceded by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words. Forward-looking statements are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company's control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements: (i) the initiation, timing, progress and results of the Company’s research, manufacturing and other development efforts; (ii) the Company’s ability to advance its products to successfully complete development and commercialization; (iii) the manufacturing, development, commercialization, and market acceptance of the Company’s products; (iv) the lack of sufficient funding to finance the product development and business operations; (v) competitive companies and technologies within the Company’s industry and introduction of competing products; (vi) the Company’s ability to establish and maintain corporate collaborations; (vii) loss of key management personnel; (viii) the scope of protection the Company is able to establish and maintain for intellectual property rights covering its products and its ability to operate its business without infringing the intellectual property rights of others; (ix) potential failure to comply with applicable health information privacy and security laws and other state and federal privacy and security laws; and (x) the difficulty of predicting actions of the USA FDA and its regulations. All forward-looking statements included in this press release are made only as of the date of this press release. The Company assumes no obligation to update any written or oral forward-looking statement unless required by law. Contact: LifeClips, Inc. Gabriel P. Rodriguez Investor Relations: (623) 261-9046 Email: erelationsgroup@gmail.com
GlobeNewswire•3 months ago
Life Clips Closes Transaction to Acquire Cognitive Apps Software Solutions Inc.
Life Clips intends to utilize Cognitive Apps speech-based AI technology to help accurately predict risk for various types of depression and mood, psychotic and anxiety-based disordersAVENTURA, Fla., April 06, 2021 (GLOBE NEWSWIRE) -- Life Clips, Inc. (OTC Pink: LCLP) (the “Company”), today announced that it has closed the acquisition of Cognitive Apps Software Solutions Inc. (Cognitive Apps), a developer of artificial intelligence (AI) applications for the healthcare industry and psychedelic research. Cognitive Apps provides an AI powered mental health analytics platform empowering businesses to measure, understand, and improve the mental well-being of their employees, patients or customers. The Cognitive Apps solution is driven to achieve the Three Pillars: improved diagnostic outcomes, better and more personalized care for individuals, and to decrease the overall costs and time for the care. An individual only needs to record their voice on a handset, iPad, or tablet. The Cognitive Apps assessment is designed to be administered as often as daily, in order to provide a more granular picture of changes in mental health over time. As a result, the Cognitive apps assessment can be routinely completed to monitor mental health and track variables that might be impacted by treatment. Dr. Manideep Gopishetty, CEO and Co-founder of Cognitive Apps, said, “Our technology is designed to measure very tiny changes in individuals mental health and is able to identify the risk factors behind it by collecting data in two forms, both voice and text. Based on the assessment, our company also deploys interactive content and chat bots for personalized care of the individuals. Overall AI is not an intruder but a multi-talented, non-biased personalized assistant which can improve the care, treatment outcomes and lifestyle of patients.” With the acquisition, Life Clips gains access to Cognitive Apps' intellectual property, including AI enabled speech-based technology, and its research and development team. Life Clips will further develop Cognitive Apps' technology for use in the development and testing of psychedelics and other molecules related to mental health indications for the treatment of various mental health disorders. Robert Grinberg, CEO and Director of Life Clips, said, "The acquisition of Cognitive Apps marks the first step in growth and expansion strategy of Life Clips. As we continue to move forward, we maintain a positive business outlook focused on achieving revenue growth, profitability and value creation for our shareholders. We expect this transaction to serve as a launchpad for Life Clips to broaden operations and expand into multiple markets." Mr. Grinberg continued, "We are enthusiastic, after months of tough negotiations and careful due diligence, to move forward with the acquisition of Cognitive Apps. As well, we are truly so pleased to work closely with Dr. Manideep Gopishetty, who will bring a tremendous amount of knowledge to the team we plan to assemble at Life Clips." Cognitive Apps delivers a comprehensive approach to well-being, supporting the whole person. Cognitive apps currently has partnerships with Ehave (OTC: EHVVF), Mycotopia (OTC: TWGL), Welmind EMR, Betterhelp, Belshare, and Movefit. Visit our corporate website at www.lifeclips.com. About Life Clips, Inc. Life Clips is the parent company of Cognitive Apps Software Solutions Inc. and distributes single-use and cordless batteries under the Mobeego brand for use in cellular phones and other mobile devices. Cognitive Apps is an AI-Powered mental health analytics platform that empowers businesses to measure, understand, and improve mental well-being of their employees, patients and customers. Drug development for mental health disorders and other cognitive impairments is hampered by the ability to identify at risk groups before the onset of clinically significant symptoms, as well as continuous assessments on the progress made by the participants. Cognitive Apps is addressing this problem by pioneering a speech-based AI technology which could help accurately predict risk for various types of depression and mood and anxiety-based disorders years before a clinical diagnosis is obtained. Our technology can help detect and monitor subtle changes in mental state by assessing individuals more frequently and more objectively than the assessments used today. Cognitive apps currently has partnerships with Ehave, Mycotopia, Welmind EMR, Betterhelp, Belshare, and Movefit. Forward-Looking Statement Disclaimer This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may be preceded by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words. Forward-looking statements are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company's control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements: (i) the initiation, timing, progress and results of the Company’s research, manufacturing and other development efforts; (ii) the Company’s ability to advance its products to successfully complete development and commercialization; (iii) the manufacturing, development, commercialization, and market acceptance of the Company’s products; (iv) the lack of sufficient funding to finance the product development and business operations; (v) competitive companies and technologies within the Company’s industry and introduction of competing products; (vi) the Company’s ability to establish and maintain corporate collaborations; (vii) loss of key management personnel; (viii) the scope of protection the Company is able to establish and maintain for intellectual property rights covering its products and its ability to operate its business without infringing the intellectual property rights of others; (ix) potential failure to comply with applicable health information privacy and security laws and other state and federal privacy and security laws; and (x) the difficulty of predicting actions of the USA FDA and its regulations. All forward-looking statements included in this press release are made only as of the date of this press release. The Company assumes no obligation to update any written or oral forward-looking statement unless required by law. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is contained under the heading "Risk Factors" in Ehave, Inc.’s Registration Statement on Form F-1 filed with the Securities and Exchange Commission (SEC) on September 24, 2015, as amended, which is available on the SEC's website, http://www.sec.gov. Contact: LifeClips, Inc. Gabriel P. Rodriguez Investor Relations: (623) 261-9046 Email: erelationsgroup@gmail.com
GlobeNewswire•5 months ago
Life Clips to Acquire Mental Health Voice-Based AI Technology Company
Acquisition will allow the Company to utilize speech-based AI technology to help accurately predict risk for various types of depression and mood and anxiety-based disorders AVENTURA, Fla., Feb. 24, 2021 (GLOBE NEWSWIRE) -- Life Clips, Inc. (OTC Pink: LCLP) (the “Company”), today announced that it has entered into a letter of intent to acquire
For more, click https://finance.yahoo.com/quote/LCLP?p=LCLP&.tsrc=fin-srch and scroll down that page for these headlines I've highlighted here:
GlobeNewswire•22 days ago
Life Clips Subsidiary Cognitive Apps Software Solutions Introduces Intuitive AI Chat Bot Solutions Delivering CBT And IPT Therapies For Mental Health Disorders
Mental health is one of the biggest pandemic issues we will face in the near futureAVENTURA, Fla., June 29, 2021 (GLOBE NEWSWIRE) -- Life Clips, Inc. (OTC Pink: LCLP) (the “Company”) today announced that its subsidiary Cognitive Apps Software has introduced a game changing Chatbot solution for both cognitive behavioral therapy (CBT) and interpersonal therapy (IPT). Cognitive Apps Chatbot is an interactive assistant that makes it easy to measure, understand, and improve mental health of a person. The soon to be released version combines cognitive behavioral therapy and elements of interpersonal psychotherapy with the company’s conversational chatbot to deliver treatment directly through patients’ phones.
The solution is backed by science and based on voice tone analysis and context analysis utilizing Cognitive Apps' proprietary artificial intelligence (AI). The chatbot interaction includes revolutionary features, such as general mood analysis, actual emotion detection, and mental health state tracking. Integration with health data gathering tools (sleep, physical activity) allows receiving data in passive mode and makes mental health analytics results more accurate and objective. The chatbot will observe and improve mental health state of the individual using it. It also allows therapists to monitor patients’ mental health level, while analyzing the efficiency of prescriptions and treatment. Many enterprises will find the chatbot useful to monitor overall company mental health level, analyze return on investment, detect early signs of burnout, depression, and/or anxiety.
The chatbot works as an individual makes daily check-ins with voice or text messages. It further analyzes his or her emotions, daily mood and mental health state. For an individual the chatbot displays analysis results and suggest suitable content. For a therapist the chatbot utilizes a dashboard to display the mental health state, wellbeing statistics, and medication history for selected groups of patients, while providing an individual-level of analytics. For an enterprise the dashboard displays the data in an encrypted & non-personalized form and illumination that drives immediate decisions.
Cognitive Apps is the creator of the popular Yuru 3-in-1 tool for understanding and managing mental health. The Company recently announced a successful launch of Yuru on Apple‘s App Store. Yuru was developed by a team of licensed psychotherapists as a personal mental health monitor that screens early signs of mental health conditions, such as stress and depression. With a 10 second voice recording Yuru utilizes vocal biomarkers to recognize an individual’s current emotional state and mood. Yuru is considered by many to be an innovative application in the field of psychological assistance, since it allows individuals to track their mental health while providing them with extensive knowledge about human development and the psychology of everyday life.
GlobeNewswire•3 months ago
Life Clips, Inc. Subsidiary Cognitive Apps Signs LOI to License Yuru Technology to Belfrics BT
AVENTURA, Fla., April 28, 2021 (GLOBE NEWSWIRE) -- Life Clips, Inc. (OTC Pink: LCLP) (the “Company”) today announced that its subsidiary Cognitive Apps Software has signed a Letter of Intent (LOI) to license its Yuru software to Malaysian based BelfricsBT for use in its products in the Southeast Asian market. BelfricsBT provides a diverse mix of Blockchain related services, including Blockchain powered smart contracts and crypto exchange software, as well as custom solutions. Cognitive Apps is the creator of the popular Yuru 3-in-1 tool for understanding and managing mental health. The Company recently announced a successful launch of Yuru on Apple‘s App Store. Yuru was developed by a team of licensed psychotherapists as a personal mental health monitor that screens early signs of mental health conditions, such as stress and depression. With a 10 second voice recording Yuru utilizes vocal biomarkers to recognize an individual’s current emotional state and mood. Yuru is considered by many to be an innovative application in the field of psychological assistance, since it allows individuals to track their mental health while providing them with extensive knowledge about human development and the psychology of everyday life. Cognitive Apps is targeting employee mental health in the next phase of its rollout of Yuru. Major employers like SAP North America, a global enterprise software company are focusing on the trend toward increased employee mental health. SAP recently announced its first-ever Global Mental Health Day, giving all of its more than 100,000 employees a mandatory day off to help them recharge and balance priorities. The digital mental health space was growing rapidly before the COVID-19 pandemic, but stress and anxiety created by the pandemic have increased demand for virtual behavioral health services. According to a recent report by Acumen Research and Consulting titled “Mental Health App Market – Global Industry Analysis, Market Size, Opportunities and Forecast, 2020-2027”, the Global Mental Health App Market is expected to grow at a CAGR of around 24.2% from 2020 to 2027 and reach the market value of over US$ 3.7 billion by 2027. The report says the global mental health app market is estimated to gain potential growth over the forecast period from 2020 to 2027 due to increasing awareness about the importance of mental health among people across the globe. Mental health apps are designed to shape up the mood of the user, additionally, these apps let users connect with the licensed mental health professional and peers who can understand what they are going through. These apps also contain lots of information about mental health that helps its users to understand better about their condition. Social stigma for mental health in some regions prevents patients from visiting the concerned organization or professional additionally bolstering the number of mental health apps downloads.i Dr. Manideep Gopishetty, CEO and Co-founder of Cognitive Apps, said, “The benefits of Yuru are clear. We can provide increased access to mental healthcare at our fingertips. Not only does Yuru provide mental healthcare to those who otherwise might not have access to it, we can personalize care to meet the exact needs of the patient. Yuru provides the potential to provide care that is more affordable, personalized, and accessible.” Robert Grinberg, CEO and of Life Clips, Inc. said, "This LOI with BelfricsBT is the first of many opportunities we will have to expand the Yuru platform. In its Global Millennial Survey last year, Deloitte said that 48% of Gen Zs and 44% of millennials felt stressed or anxious all or most of the time from long-term career and financial outlooks, family welfare, and environmental concerns, among other issues. Our goal is to help with these mental health issues and improve the quality of life for those who are affected." Life Clips appreciates all of its shareholders and would like to provide them with complimentary lifetime free access to the Yuru app. Shareholders are invited to download the app on the Apple store using this link https://apps.apple.com/us/app/yuru-stress-test-self-care/id1502398978. About Life Clips, Inc. Life Clips is the parent company of Cognitive Apps Software Solutions Inc. and distributes single-use and cordless batteries under the Mobeego brand for use with cellular phones and other mobile devices. Cognitive Apps is an AI-Powered mental health analytics platform that empowers businesses to measure, understand, and improve mental well-being of their employees, patients and customers. Drug development for mental health disorders and other cognitive impairments is hampered by the inability to identify at risk groups before the onset of clinically significant symptoms, as well as continuous assessments on the progress made by the participants. Cognitive Apps is addressing this problem by pioneering a speech-based AI technology which could help accurately predict risk for various types of depression and mood and anxiety-based disorders years before a clinical diagnosis is obtained. Our technology can help detect and monitor subtle changes in mental state by assessing individuals more frequently and more objectively than the assessments used today. www.lifeclips.com About BelfricsBT BelfricsBT is the leading provider of Distributed Ledger Technology to various sectors. The Company is a group of Blockchain experts armed with rich corporate experience. Belfrics BT provides any and all kinds of Blockchain related services, including blockchain powered smart contracts and crypto exchange software. BelfricsBT's aim is to generate revolutionary Blockchain concepts and convert them into Enterprise solutions that can solve real business problems. Its coders have the experience of developing completely fresh Blockchains as well as specific blockchain applications. BelfricsBT specializes in converting complex transactions and sequence into codes. Its management team has worked with clients from various industries and geographies. As a result, BelfricsBT's team is well aware of core problems of each of these industries. www.belfricsbt.com Forward-Looking Statement Disclaimer This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may be preceded by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words. Forward-looking statements are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company's control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements: (i) the initiation, timing, progress and results of the Company’s research, manufacturing and other development efforts; (ii) the Company’s ability to advance its products to successfully complete development and commercialization; (iii) the manufacturing, development, commercialization, and market acceptance of the Company’s products; (iv) the lack of sufficient funding to finance the product development and business operations; (v) competitive companies and technologies within the Company’s industry and introduction of competing products; (vi) the Company’s ability to establish and maintain corporate collaborations; (vii) loss of key management personnel; (viii) the scope of protection the Company is able to establish and maintain for intellectual property rights covering its products and its ability to operate its business without infringing the intellectual property rights of others; (ix) potential failure to comply with applicable health information privacy and security laws and other state and federal privacy and security laws; and (x) the difficulty of predicting actions of the USA FDA and its regulations. All forward-looking statements included in this press release are made only as of the date of this press release. The Company assumes no obligation to update any written or oral forward-looking statement unless required by law. For LifeClips, Inc. Investor Relations Please Contact: David Kugelman(866) 692-6847 Toll Free - U.S. & Canada(404) 281-8556 Mobile, WhatsApp, Signal, and TelegramSkype: kugsusadk@atlcp.com https://www.linkedin.com/in/davidkugelman i https://bit.ly/3vid5rH
GlobeNewswire•3 months ago
Life Clips, Inc. Subsidiary Cognitive Apps Announces Successful Launch of Yuru Mental Health App
AVENTURA, Fla., April 19, 2021 (GLOBE NEWSWIRE) -- Life Clips, Inc. (OTC Pink: LCLP) (the “Company”) today announced that its subsidiary Cognitive Apps Software has completed a successful launch of its Yuru 3-in-1 tool for understanding and managing your mental health. The initial results on Apple‘s App Store showed a weekly download conversion rate of 5.6% on more than 189,000 impressions and 19,900 product page views. App Units were 8,500 with average sales per paying user of $28.10. App Units are the number of first-time paid and free app purchases made on the App Store using iOS 8 and tvOS 9 or later. App updates and downloads from the same Apple ID onto other devices, and redownloads to the same device are not counted. Yuru is an innovative application in the field of psychological assistance that has been developed by a team of licensed psychotherapists. Yuru is a personal mental health monitor that screens early signs of mental health conditions, such as stress and depression. In just 10 seconds, it makes use of vocal biomarkers to recognize your real current emotional state and mood, while tracking your mental health. Yuru also provides you with extensive knowledge about human development and the psychology of everyday life. Yuru involves tracking of your emotions and mood, analysis of your mental state, and treatment for improving your mental well-being. Life Clips appreciates all of its shareholders and would like to provide them with complimentary lifetime free access to the Yuru app. Shareholders are invited to download the app on the Apple store using this link https://apps.apple.com/us/app/yuru-stress-test-self-care/id1502398978. According to a December 03, 2020 article in The Harvard Business Review, the U.S. has long suffered from a severe shortage of mental health care services. The pandemic has put a spotlight on the effectiveness and wide availability of digital and virtual mental health care, and by doing so might have thrown a lifeline to our mental health system. The article went on to say sixty percent of young people with major depression received no mental health treatment in 2017-2018, and one quarter of adults with mental illness reported an unmet need for treatment. In the U.S., 55% of counties have no psychiatrist, psychologist or social worker, and 70% don’t have a single child psychiatrist. Queues for substance abuse care can be weeks long; 70% of those who needed substance use treatment in 2017 did not receive it. To make it worse, many practices have closed or reduced their capacity in response to pandemic health concerns. As a result, mental health vendors are combining digital tools and virtual care to create a robust ecosystem for end-to-end patient care, including steering patients to in-person care when needed. This combination of tools provides the mental health care system with scalable solutions and increased flexibility while improving access and convenience for consumers. Because of these benefits, the majority of employer-sponsored health plans now offer virtual and digital options for mental health care.i Dr. Manideep Gopishetty, CEO and Co-founder of Cognitive Apps, said, “The Yuru team is very pleased to see our numbers climb following this initial introduction of our mental health app. We believed our messaging was going to result in a strong source of new users due to the enormity of the market. It is the right time to aggressively market our online mental health platform. These strong early results are encouraging.” Robert Grinberg, CEO and President of Life Clips, Inc. said, "I would like to congratulate Dr. Gopishetty and his team on a successful rollout of Yuru. Yuru is a true mental health companion that warns you if it notices that you need professional guidance from a therapist. It nudges you to pay attention to your mental state if there is a change in your stress level. By analyzing vocal biomarkers received from your voice, Yuru reports a spectrum of your current emotions, your daily mood, and the overall status of your mental health. We look forward to expanding the Yuru platform, as well as making future acquisitions that are in line with our business plan." About Life Clips, Inc. Life Clips is the parent company of Cognitive Apps Software Solutions Inc. and distributes single-use and cordless batteries under the Mobeego brand for use with cellular phones and other mobile devices. Cognitive Apps is an AI-Powered mental health analytics platform that empowers businesses to measure, understand, and improve mental well-being of their employees, patients and customers. Drug development for mental health disorders and other cognitive impairments is hampered by the inability to identify at risk groups before the onset of clinically significant symptoms, as well as continuous assessments on the progress made by the participants. Cognitive Apps is addressing this problem by pioneering a speech-based AI technology which could help accurately predict risk for various types of depression and mood and anxiety-based disorders years before a clinical diagnosis is obtained. Our technology can help detect and monitor subtle changes in mental state by assessing individuals more frequently and more objectively than the assessments used today. Forward-Looking Statement Disclaimer This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may be preceded by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words. Forward-looking statements are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company's control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements: (i) the initiation, timing, progress and results of the Company’s research, manufacturing and other development efforts; (ii) the Company’s ability to advance its products to successfully complete development and commercialization; (iii) the manufacturing, development, commercialization, and market acceptance of the Company’s products; (iv) the lack of sufficient funding to finance the product development and business operations; (v) competitive companies and technologies within the Company’s industry and introduction of competing products; (vi) the Company’s ability to establish and maintain corporate collaborations; (vii) loss of key management personnel; (viii) the scope of protection the Company is able to establish and maintain for intellectual property rights covering its products and its ability to operate its business without infringing the intellectual property rights of others; (ix) potential failure to comply with applicable health information privacy and security laws and other state and federal privacy and security laws; and (x) the difficulty of predicting actions of the USA FDA and its regulations. All forward-looking statements included in this press release are made only as of the date of this press release. The Company assumes no obligation to update any written or oral forward-looking statement unless required by law. Contact: LifeClips, Inc. Gabriel P. Rodriguez Investor Relations: (623) 261-9046 Email: erelationsgroup@gmail.com i https://hbr.org/2020/12/digital-tools-are-revolutionizing-mental-health-care-in-the-u-s
GlobeNewswire•3 months ago
Life Clips, Inc. Subsidiary Cognitive Apps Recognized as One of the Most Promising AI Startups in the Healthcare and Technology Space
AVENTURA, Fla., April 15, 2021 (GLOBE NEWSWIRE) -- Life Clips, Inc. (OTC Pink: LCLP) (the “Company”) today announced that its subsidiary Cognitive Apps Software recently participated in the February 2021 Y Combinator cohort receiving an award as one of the most promising Artificial Intelligence (AI) startups in the space of healthcare and technology. This success has further validated Cognitive Apps proof of concept and has energized the entire Cognitive Apps team and motivated us to push the boundaries of innovation in the space of AI. Following this success, Cognitive Apps is developing a series of new features rolling out in coming weeks including speech to text for clinical documentation purposes in the healthcare and a series of intuitive chat bots targeting various mental health care indications. Additionally, Cognitive Apps has signed three LOI’s for the licensing of its technology to other technological companies. Cognitive Apps plans to apply its existing technology, as well as the new technologies being rolled out, disrupting industries with intuitive chatbots targeting insurance companies and corporate wellness, diagnostic monitoring tools for outpatient for hospitals and clinics, and AI diagnostic algorithms for mental healthcare clinical trials. The global chatbot market size was estimated at $352.8 million in 2019 and is expected to reach $1.250 billion by 2025.i Dr. Manideep Gopishetty, CEO and Co-founder of Cognitive Apps, said, “Receiving recognition and an award from such a highly regarded organization that has produced over 25 unicorns, is a tremendous achievement for Cognitive Apps. With this spirit and responsibility my team and I plan to push our innovation to the next level, where it can have profound impact on the mental health care and AI technology sector for the next decade.” "We are honored to have Cognitive Apps recognized as one of the most promising AI startups in healthcare and technology," said Robert Grinberg, CEO and of Life Clips, Inc. "I believe our recent acquisition of Cognitive Apps will be very beneficial to our shareholders. We look forward to building a competitive brand as we move forward with other acquisitions." About Life Clips, Inc. Life Clips is the parent company of Cognitive Apps Software Solutions Inc. and distributes single-use and cordless batteries under the Mobeego brand for use with cellular phones and other mobile devices. Cognitive Apps is an AI-Powered mental health analytics platform that empowers businesses to measure, understand, and improve mental well-being of their employees, patients and customers. Drug development for mental health disorders and other cognitive impairments is hampered by the inability to identify at risk groups before the onset of clinically significant symptoms, as well as continuous assessments on the progress made by the participants. Cognitive Apps is addressing this problem by pioneering a speech-based AI technology which could help accurately predict risk for various types of depression and mood and anxiety-based disorders years before a clinical diagnosis is obtained. Our technology can help detect and monitor subtle changes in mental state by assessing individuals more frequently and more objectively than the assessments used today. Forward-Looking Statement Disclaimer This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may be preceded by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words. Forward-looking statements are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company's control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements: (i) the initiation, timing, progress and results of the Company’s research, manufacturing and other development efforts; (ii) the Company’s ability to advance its products to successfully complete development and commercialization; (iii) the manufacturing, development, commercialization, and market acceptance of the Company’s products; (iv) the lack of sufficient funding to finance the product development and business operations; (v) competitive companies and technologies within the Company’s industry and introduction of competing products; (vi) the Company’s ability to establish and maintain corporate collaborations; (vii) loss of key management personnel; (viii) the scope of protection the Company is able to establish and maintain for intellectual property rights covering its products and its ability to operate its business without infringing the intellectual property rights of others; (ix) potential failure to comply with applicable health information privacy and security laws and other state and federal privacy and security laws; and (x) the difficulty of predicting actions of the USA FDA and its regulations. All forward-looking statements included in this press release are made only as of the date of this press release. The Company assumes no obligation to update any written or oral forward-looking statement unless required by law. Contact: Life Clips, Inc.David L. Kugelman(404) 856-9157 Office(866) 692-6847 Toll Free - U.S. & Canada(404) 281-8556 Mobile and WhatsAppSkype: kugsusadk@atlcp.com__________________ i https://www.grandviewresearch.com/industry-analysis/chatbot-market#:~:text=The%20global%20chatbot%20market%20size,USD%20430.9%20million%20in%202020.&text=The%20global%20chatbot%20market%20is,USD%201%2C250.1%20million%20by%202025.
GlobeNewswire•3 months ago
Life Clips, Inc. Issues CEO Letter to Stockholders, Reports on Outlook for Remainder of 2021
AVENTURA, Fla., April 12, 2021 (GLOBE NEWSWIRE) -- Life Clips, Inc. (OTC Pink: LCLP) (the “Company”) today announced that Robert Grinberg, President, Chief Executive Officer and Chairman, has issued a letter to Life Clips' shareholders. The full text is as follows: To My Fellow Stockholders, Over the course of the last few months, Life Clips, Inc. has made significant progress in advancing its strategic plan and we are off to a tremendous start. First, I am proud to report that Life Clips is current in its status as a fully reporting company with the SEC. This took many months of hard work by our CFO and her team of professionals. One of our primary goals moving forward will be corporate transparency. I am a firm believer that transparency pays off in the financial markets in the form of less risk to investors and a lower cost of capital for our Company, which will hopefully translate into a higher valuation. Maintaining our status as a reporting company is the foundation of providing transparency to our shareholders. Even though we are just getting started, I think it is important to discuss, not just the accomplishments of our management team, but the potential we see in Life Clips' business plan in the future. First and foremost, we were very proud to make the announcement to our shareholders this week that we closed our acquisition of Cognitive Apps Software Solutions Inc. Cognitive Apps is a developer of AI applications for the healthcare industry with applications in psychedelic research. Our enthusiasm for Cognitive Apps is based on the premise that Life Clips is now in two of the fastest growing sectors, AI and psychedelics. In addition to entering these fast-growing markets with the acquisition of Cognitive Apps, Life Clips has attained what we believe to be some of the most talented individuals in the business. Dr. Manideep Gopishetty, CEO and Co-founder of Cognitive Apps, holds several advanced degrees, including an MD and an MBA. In addition to education credentials, Dr. Gopishetty also brings a tremendous amount of experience in neuromarketing, neuroeconomics, consumer behavior, and consumer psychology in such diverse fields as healthcare, biotechnology and pharmaceuticals, SAAS, and artificial intelligence. Cognitive Apps provides an AI powered mental health analytics platform empowering businesses to measure, understand, and improve the mental well-being of their employees, patients or customers. Cognitive Apps was designed specifically to improve diagnostic outcomes, population health, and to provide a better care experience. This is accomplished by processing data into actionable insight that impacts operational benefits and patient outcomes. By recording an individual’s voice periodically on a handset, iPad, or tablet, the Cognitive Apps assessment is designed to provide a picture of changes in mental health. The Cognitive Apps’ assessment will allow us to monitor mental health and track variables that might be impacted by treatment. Cognitive Apps has participated in a Y-Combinator cohort winning credits from Google, Amazon and Microsoft, and is beginning development of AI algorithms for PTSD and Anxiety. At the root of our business plan, the force that drives us will be to improve mental health and combat mental illness. Nearly one in five U.S. adults experience some form of mental illness and one adult in 24 has a serious mental illness. Mental illness is treatable, and our mission is to treat even those with serious mental illness. Depression is a common mental disorder affecting more than 264 million people worldwide. Mental health experts have found a strong link between loneliness, depression, and drug overdoses. According to national drug abuse data, drug overdoses have increased 42% since Covid-19. Serious mental illness costs the U.S. economy $193.2 billion in lost earnings each year, but the problem is much larger globally. Mental health disorders are on the rise in every country and could cost the global economy up to $16 trillion annually by 2030. The numbers are staggering but are outweighed by the loss of human lives. We look forward to positioning Life Clips to have even a small role in the global mental health crisis. Mental health is something every one of us should be talking about. Acquiring Cognitive Apps is the first piece of the business strategy we have developed for Life Clips. Management’s business strategy targets revenue growth, profitability and value creation for our shareholders. This initial acquisition is the first of several that will allow us to broaden operations and expand into multiple markets. Since both the healthcare and psychedelic sectors are made up of many small companies, we will also plan to join forces with both publicly traded and privately held enterprises to form partnerships, joint ventures, and alliances. Life Clips also has the Mobeego line of affordable, single-use, cordless batteries that provide an instant charge for your phone when you don't have access to a wired power source and is ideally suited for emergency situations having a long shelf life, holding a charge many times longer than any mobile power bank. Mobeego connects to your mobile phone’s charging socket, and is compatible with all iPhones 5 and up, as well as most Micro USB devices. Mobeego consists of two parts: a disposable battery can that extends a mobile phone’s life by 1-4 hours, and a reusable, ultra-compact adapter. When you're ready to use Mobeego, simply connect the can to your mobile phone via the adapter, and charging will begin immediately when you switch it on. After you finish using the can, save the adapter and recycle the can. Unlike a rechargeable power bank, the Mobeego won’t lose charge when stored for extended periods, such as a part of an emergency kit. I realize it is early in the game, but we are delighted with our progress to date and are very excited about our momentum, as well as Life Clips' prospects. I would like to thank our shareholders for their vote of confidence. I learned a long time ago respect is earned, and my goal is to earn the respect of shareholders by building a successful company. We look forward to continued success in 2021 and beyond. About Life Clips, Inc. Life Clips is the parent company of Cognitive Apps Software Solutions Inc. and distributes single-use and cordless batteries under the Mobeego brand for use with cellular phones and other mobile devices. Cognitive Apps is an AI-Powered mental health analytics platform that empowers businesses to measure, understand, and improve mental well-being of their employees, patients and customers. Drug development for mental health disorders and other cognitive impairments is hampered by the inability to identify at risk groups before the onset of clinically significant symptoms, as well as continuous assessments on the progress made by the participants. Cognitive Apps is addressing this problem by pioneering a speech-based AI technology which could help accurately predict risk for various types of depression and mood and anxiety-based disorders years before a clinical diagnosis is obtained. Our technology can help detect and monitor subtle changes in mental state by assessing individuals more frequently and more objectively than the assessments used today. Forward-Looking Statement Disclaimer This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may be preceded by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words. Forward-looking statements are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company's control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements: (i) the initiation, timing, progress and results of the Company’s research, manufacturing and other development efforts; (ii) the Company’s ability to advance its products to successfully complete development and commercialization; (iii) the manufacturing, development, commercialization, and market acceptance of the Company’s products; (iv) the lack of sufficient funding to finance the product development and business operations; (v) competitive companies and technologies within the Company’s industry and introduction of competing products; (vi) the Company’s ability to establish and maintain corporate collaborations; (vii) loss of key management personnel; (viii) the scope of protection the Company is able to establish and maintain for intellectual property rights covering its products and its ability to operate its business without infringing the intellectual property rights of others; (ix) potential failure to comply with applicable health information privacy and security laws and other state and federal privacy and security laws; and (x) the difficulty of predicting actions of the USA FDA and its regulations. All forward-looking statements included in this press release are made only as of the date of this press release. The Company assumes no obligation to update any written or oral forward-looking statement unless required by law. Contact: LifeClips, Inc. Gabriel P. Rodriguez Investor Relations: (623) 261-9046 Email: erelationsgroup@gmail.com
GlobeNewswire•3 months ago
Life Clips Closes Transaction to Acquire Cognitive Apps Software Solutions Inc.
Life Clips intends to utilize Cognitive Apps speech-based AI technology to help accurately predict risk for various types of depression and mood, psychotic and anxiety-based disordersAVENTURA, Fla., April 06, 2021 (GLOBE NEWSWIRE) -- Life Clips, Inc. (OTC Pink: LCLP) (the “Company”), today announced that it has closed the acquisition of Cognitive Apps Software Solutions Inc. (Cognitive Apps), a developer of artificial intelligence (AI) applications for the healthcare industry and psychedelic research. Cognitive Apps provides an AI powered mental health analytics platform empowering businesses to measure, understand, and improve the mental well-being of their employees, patients or customers. The Cognitive Apps solution is driven to achieve the Three Pillars: improved diagnostic outcomes, better and more personalized care for individuals, and to decrease the overall costs and time for the care. An individual only needs to record their voice on a handset, iPad, or tablet. The Cognitive Apps assessment is designed to be administered as often as daily, in order to provide a more granular picture of changes in mental health over time. As a result, the Cognitive apps assessment can be routinely completed to monitor mental health and track variables that might be impacted by treatment. Dr. Manideep Gopishetty, CEO and Co-founder of Cognitive Apps, said, “Our technology is designed to measure very tiny changes in individuals mental health and is able to identify the risk factors behind it by collecting data in two forms, both voice and text. Based on the assessment, our company also deploys interactive content and chat bots for personalized care of the individuals. Overall AI is not an intruder but a multi-talented, non-biased personalized assistant which can improve the care, treatment outcomes and lifestyle of patients.” With the acquisition, Life Clips gains access to Cognitive Apps' intellectual property, including AI enabled speech-based technology, and its research and development team. Life Clips will further develop Cognitive Apps' technology for use in the development and testing of psychedelics and other molecules related to mental health indications for the treatment of various mental health disorders. Robert Grinberg, CEO and Director of Life Clips, said, "The acquisition of Cognitive Apps marks the first step in growth and expansion strategy of Life Clips. As we continue to move forward, we maintain a positive business outlook focused on achieving revenue growth, profitability and value creation for our shareholders. We expect this transaction to serve as a launchpad for Life Clips to broaden operations and expand into multiple markets." Mr. Grinberg continued, "We are enthusiastic, after months of tough negotiations and careful due diligence, to move forward with the acquisition of Cognitive Apps. As well, we are truly so pleased to work closely with Dr. Manideep Gopishetty, who will bring a tremendous amount of knowledge to the team we plan to assemble at Life Clips." Cognitive Apps delivers a comprehensive approach to well-being, supporting the whole person. Cognitive apps currently has partnerships with Ehave (OTC: EHVVF), Mycotopia (OTC: TWGL), Welmind EMR, Betterhelp, Belshare, and Movefit. Visit our corporate website at www.lifeclips.com. About Life Clips, Inc. Life Clips is the parent company of Cognitive Apps Software Solutions Inc. and distributes single-use and cordless batteries under the Mobeego brand for use in cellular phones and other mobile devices. Cognitive Apps is an AI-Powered mental health analytics platform that empowers businesses to measure, understand, and improve mental well-being of their employees, patients and customers. Drug development for mental health disorders and other cognitive impairments is hampered by the ability to identify at risk groups before the onset of clinically significant symptoms, as well as continuous assessments on the progress made by the participants. Cognitive Apps is addressing this problem by pioneering a speech-based AI technology which could help accurately predict risk for various types of depression and mood and anxiety-based disorders years before a clinical diagnosis is obtained. Our technology can help detect and monitor subtle changes in mental state by assessing individuals more frequently and more objectively than the assessments used today. Cognitive apps currently has partnerships with Ehave, Mycotopia, Welmind EMR, Betterhelp, Belshare, and Movefit. Forward-Looking Statement Disclaimer This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may be preceded by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words. Forward-looking statements are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company's control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements: (i) the initiation, timing, progress and results of the Company’s research, manufacturing and other development efforts; (ii) the Company’s ability to advance its products to successfully complete development and commercialization; (iii) the manufacturing, development, commercialization, and market acceptance of the Company’s products; (iv) the lack of sufficient funding to finance the product development and business operations; (v) competitive companies and technologies within the Company’s industry and introduction of competing products; (vi) the Company’s ability to establish and maintain corporate collaborations; (vii) loss of key management personnel; (viii) the scope of protection the Company is able to establish and maintain for intellectual property rights covering its products and its ability to operate its business without infringing the intellectual property rights of others; (ix) potential failure to comply with applicable health information privacy and security laws and other state and federal privacy and security laws; and (x) the difficulty of predicting actions of the USA FDA and its regulations. All forward-looking statements included in this press release are made only as of the date of this press release. The Company assumes no obligation to update any written or oral forward-looking statement unless required by law. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is contained under the heading "Risk Factors" in Ehave, Inc.’s Registration Statement on Form F-1 filed with the Securities and Exchange Commission (SEC) on September 24, 2015, as amended, which is available on the SEC's website, http://www.sec.gov. Contact: LifeClips, Inc. Gabriel P. Rodriguez Investor Relations: (623) 261-9046 Email: erelationsgroup@gmail.com
GlobeNewswire•5 months ago
Life Clips to Acquire Mental Health Voice-Based AI Technology Company
Acquisition will allow the Company to utilize speech-based AI technology to help accurately predict risk for various types of depression and mood and anxiety-based disorders AVENTURA, Fla., Feb. 24, 2021 (GLOBE NEWSWIRE) -- Life Clips, Inc. (OTC Pink: LCLP) (the “Company”), today announced that it has entered into a letter of intent to acquire
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
